These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35953578)

  • 1. Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments.
    Massa F; Franciotta D; Grisanti S; Roccatagliata L; Morbelli S; Beltramini S; Uccelli A; Schenone A; Benedetti L
    Neurol Sci; 2022 Nov; 43(11):6441-6447. PubMed ID: 35953578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratoma Removal, Steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in Anti-NMDAR Encephalitis.
    Lee WJ; Lee ST; Shin YW; Lee HS; Shin HR; Kim DY; Kim S; Lim JA; Moon J; Park KI; Kim HS; Chu K; Lee SK
    Neurotherapeutics; 2021 Jan; 18(1):474-487. PubMed ID: 32880854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour.
    Wang BJ; Wang CJ; Zeng ZL; Yang Y; Guo SG
    J Neurol Sci; 2017 Jun; 377():127-132. PubMed ID: 28477682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
    Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
    Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
    Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
    Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
    Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
    Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
    Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; ; Anlar B; Armangue T; Benseler S; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sartori S; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK
    JAMA Neurol; 2021 Nov; 78(11):1333-1344. PubMed ID: 34542573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auto-immune anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: three case reports.
    Bashiri FA; Al-Rasheed AA; Hassan SM; Hamad MHA; El Khashab HY; Kentab AY; AlBadr FB; Salih MA
    Paediatr Int Child Health; 2017 Aug; 37(3):222-226. PubMed ID: 27329512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different FDG-PET metabolic patterns of anti-AMPAR and anti-NMDAR encephalitis: Case report and literature review.
    Wei YC; Tseng JR; Wu CL; Su FC; Weng WC; Hsu CC; Chang KH; Wu CF; Hsiao IT; Lin CP
    Brain Behav; 2020 Mar; 10(3):e01540. PubMed ID: 31985135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSV encephalitis triggered anti-NMDAR encephalitis: a case report.
    Hu S; Lan T; Bai R; Jiang S; Cai J; Ren L
    Neurol Sci; 2021 Mar; 42(3):857-861. PubMed ID: 33420613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-NMDAR Encephalitis with Poor Recovery on Steroid Pulse and IVIg: Practical Approach to Intensive Immunotherapy].
    Hara M; Nakajima H
    Brain Nerve; 2022 May; 74(5):433-442. PubMed ID: 35589628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
    Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
    Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral (18)FluoroDeoxy-Glucose Positron Emission Tomography in paediatric anti N-methyl-D-aspartate receptor encephalitis: A case series.
    Lagarde S; Lepine A; Caietta E; Pelletier F; Boucraut J; Chabrol B; Milh M; Guedj E
    Brain Dev; 2016 May; 38(5):461-70. PubMed ID: 26542469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-NMDAR Encephalitis with Poor Recovery on Steroid Pulse and IVIg: Second-Line Immunotherapies and Prediction of Prognosis].
    Kimura A
    Brain Nerve; 2022 May; 74(5):443-448. PubMed ID: 35589629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial spin labeling perfusion imaging in an infant with anti-N-methyl-D-aspartate receptor encephalitis: A case report.
    Watanabe Y; Sano F; Fukao T; Shimizu T; Sawanobori E; Kobayashi A; Fujioka K; Yagasaki H; Inukai T; Kaga Y
    Brain Dev; 2022 Jun; 44(6):405-409. PubMed ID: 35346541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab as Second-Line Treatment in Anti-NMDAR Encephalitis after Herpes Simplex Encephalitis in Children.
    Carrascosa-García P; Oviedo-Melgares L; Torres-Fernández D; Blázquez-Gamero D; Armangué T; Vila-Bedmar S; Prieto-Tato L; Miranda-Herrero C; Santos-Sebastián M; Rincón-López EM; Fernández-Cooke E
    Indian J Pediatr; 2022 Oct; 89(10):1031-1033. PubMed ID: 35467320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
    de Montmollin E; Demeret S; Brulé N; Conrad M; Dailler F; Lerolle N; Navellou JC; Schwebel C; Alves M; Cour M; Engrand N; Tonnelier JM; Maury E; Ruckly S; Picard G; Rogemond V; Magalhaes É; Sharshar T; Timsit JF; Honnorat J; Sonneville R;
    Am J Respir Crit Care Med; 2017 Feb; 195(4):491-499. PubMed ID: 27552490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of intravenous immunoglobulin versus intravenous methylprednisolone treatment in anti-N-methyl-d-aspartate receptor encephalitis.
    Gong X; Luo R; Liu J; Guo K; Li A; Liu X; Liu Y; Zhou D; Hong Z
    Eur J Neurol; 2022 Apr; 29(4):1117-1127. PubMed ID: 34918418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with immunoadsorption therapy in four patients with severe and refractory anti-N-methyl-D-aspartate receptor encephalitis.
    Yang Y; Zhang B; Li M; Li J
    J Clin Apher; 2021 Dec; 36(6):886-892. PubMed ID: 34520046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.